Healthcare firms discover ways to use VR to treat neurological diseases, says GlobalData
The global VR market to grow at a compound annual growth rate of 13% from $7 billion in 2018 to $28 billion in 2030.
The global VR market to grow at a compound annual growth rate of 13% from $7 billion in 2018 to $28 billion in 2030.
Availability of pharmaceutical-grade materials with broad API compatibility key to advancing drug delivery solutions
Agreement strengthens Evonik’s track record as leading contract development and manufacturing organization (CDMO)
68% of children on a higher dose of Dupixent achieved histological disease remission at week 16
Acquisition brings leading sickle cell disease portfolio and pipeline to Pfizer with potential to address critical needs in an underserved patient community
This new initiative will cater to the increasing number of patients in Karnataka in need of heart and lung Failure management and transplant
To set up 50 lifestyle modification centres across the UAE in the next 24 months
Lenalidomide is used to treat various types of cancers.
Expanding precision medicine, ARTIS icono is designed to enable a wide procedure mix in a single interventional suite
Cariprazine is an atypical antipsychotic indicated for the treatment of schizophrenia and acute treatment of manic or mixed episodes associated with bipolar I disorder
Subscribe To Our Newsletter & Stay Updated